GlassScriptPhysician profile
Michael Eric Bristow
NPI 1003312539
$3,974.15
in general payments reported to CMS, 2019-2025
20 companies · $78.91 in 2025
The $78.91 reported for 2025 was less than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,447 · 2022: $1,043 · 2023: $1,021 · 2024: $385 · 2025: $78.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,484.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $526.32 | 2021-2024 | Cardiomems, Confirm Rx |
| Merck Sharp & Dohme LLC | $492.64 | 2021-2024 | Verquvo |
| Boston Scientific Corporation | $437.34 | 2021-2024 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $353.75 | 2021-2023 | Venaseal, Closurefast |
| Novartis Pharmaceuticals Corporation | $347.70 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $270.69 | 2021-2024 | Farxiga |
| Pfizer INC. | $211.57 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $201.36 | 2021-2024 | Jardiance |
| Impulse Dynamics (USA) INC. | $167.24 | 2021-2023 | Optimizer |
| Biosense Webster, INC. | $166.75 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $158.62 | 2021-2024 | Xarelto |
| Philips North America LLC | $154.41 | 2022 | |
| Biotronik INC. | $133.77 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $98.67 | 2023-2024 | Lifevest |
| Kestra Medical Technology Services, INC. | $86.24 | 2024-2025 | Assure Wcd |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $58.70 | 2021-2024 | Eliquis |
| Abiomed | $34.32 | 2023 | Impella |
| Actelion Pharmaceuticals US, INC. | $30.43 | 2023 | Uptravi, Opsumit |
| Cvrx, INC. | $22.75 | 2022 | |
| Amgen INC. | $20.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bristow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.